Skip to main content
76°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by GlobeNewswire
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
99
100
Next >
Annovis to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 02, 2025
From
Annovis Bio Inc.
Via
GlobeNewswire
Tickers
ANVS
Vielight Neuro Technology Gains Traction Across Professional Sports, Powering Champions with Evidence-Backed Results
September 02, 2025
From
Vielight Inc.
Via
GlobeNewswire
IRADIMED CORPORATION Announces Board Transition: Anthony Vuoto Retires, Joe Kiani Appointed as New Director
September 02, 2025
From
iRadimed Corporation
Via
GlobeNewswire
Tickers
IRMD
Werewolf Therapeutics to Participate in the Upcoming H.C. Wainwright 27th Annual Global Investment Conference
September 02, 2025
From
Werewolf Therapeutics, Inc.
Via
GlobeNewswire
Tickers
HOWL
Camposol Holding PLC reports Preliminary Second Quarter and First Half 2025 Results.
September 02, 2025
From
Camposol SA
Via
GlobeNewswire
Titomic Selects Amaero as Sole Supplier of Spherical Powders
September 02, 2025
From
Amaero Ltd
Via
GlobeNewswire
Tickers
AMROF
ASX:3DA
ASX:TTT
Perfect Moment to Present at the 2025 Gateway Conference on September 4th
September 02, 2025
From
Perfect Moment Ltd.
Via
GlobeNewswire
Tickers
PMNT
GDEV Strengthens Strategic Partnership with Royal Ark as Zombie Miner Reaches TOP-1 Position in its Genre
September 02, 2025
From
GDEV Inc.
Via
GlobeNewswire
Tickers
GDEV
Lisata Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 02, 2025
From
Lisata Therapeutics, Inc.
Via
GlobeNewswire
Tickers
LSTA
Calidi Biotherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 02, 2025
From
Calidi Biotherapeutics, Inc
Via
GlobeNewswire
Rezolve Ai to Announce Strong First Half 2025 Results and Accelerated Growth Momentum
September 02, 2025
From
Rezolve AI Ltd
Via
GlobeNewswire
Tickers
RZLV
Prairie Operating Co. Provides Operations Update
September 02, 2025
From
Prairie Operating Co.
Via
GlobeNewswire
Tickers
PROP
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director
September 02, 2025
From
KALA BIO, Inc.
Via
GlobeNewswire
Tickers
KALA
Department of Defense (DoD) Awards Nearly $1 Million to Steadman Philippon Research Institute (SPRI) for Breakthrough Study on Extracellular Vesicles Therapeutic for Joint Regeneration
September 02, 2025
From
Steadman Philippon Research Institute
Via
GlobeNewswire
LanzaTech, Mibelle Group, and Fraunhofer IGB Achieve Technology Breakthrough with Production of Palm Oil Substitute
September 02, 2025
From
LanzaTech Inc.
Via
GlobeNewswire
Tickers
LNZA
LNZAW
Highridge Medical Acquires Innovative Products from Accelus to Expand Capabilities in Spine Surgery
September 02, 2025
From
Highridge Medical
Via
GlobeNewswire
4DMT Announces Leadership Expansion with Proven Late-Stage Executives to Drive 4D-150 Execution and BLA Readiness
September 02, 2025
From
4D Molecular Therapeutics, Inc.
Via
GlobeNewswire
Tickers
FDMT
zerohash Trust Company is Approved to Launch
September 02, 2025
From
Zero Hash
Via
GlobeNewswire
Hopebridge Continues to Grow Autism Therapy Services in Founding State of Indiana
September 02, 2025
From
Hopebridge
Via
GlobeNewswire
Emergent BioSolutions Awarded $30 Million Contract Modification for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted), a Two-Dose Anthrax Vaccine for Post-Exposure Prophylaxis Use
September 02, 2025
From
Emergent BioSolutions
Via
GlobeNewswire
Tickers
EBS
Phillips Edison & Company Declares Quarterly Dividends; Increases Monthly Dividend Distribution by 5.7%
September 02, 2025
From
Phillips Edison & Company, Inc.
Via
GlobeNewswire
Tickers
PECO
Constellation Brands Updates Fiscal 2026 Outlook
September 02, 2025
From
Constellation Brands, Inc.
Via
GlobeNewswire
Tickers
STZ
Habit Burger & Grill Unveils Its New Sirloin Steak Sandwich
September 02, 2025
From
Habit Burger & Grill
Via
GlobeNewswire
Theratechnologies Announces Independent Proxy Advisor Firms ISS and Glass Lewis Recommend Shareholders Vote “FOR” the Proposed Plan of Arrangement with Future Pak
September 02, 2025
From
Theratechnologies
Via
GlobeNewswire
Tickers
THTX
TSX:TH
Codere Online Announces Chief Financial Officer Transition to New Role
September 02, 2025
From
Codere Online Luxembourg, S.A.
Via
GlobeNewswire
Tickers
CDRO
CDROW
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 02, 2025
From
Abeona Therapeutics Inc.
Via
GlobeNewswire
Tickers
ABEO
BridgeBio to Present Phase 2 Proof-of-Concept Data for Encaleret in Post-Surgical Hypoparathyroidism
September 02, 2025
From
BridgeBio Pharma, Inc.
Via
GlobeNewswire
Tickers
BBIO
ASP Isotopes Issues Letter to Shareholders
September 02, 2025
From
ASP Isotopes Inc.
Via
GlobeNewswire
Tickers
ASPI
Digi Power X Expands Digital Asset Holdings and Accelerates Pivot to AI Infrastructure with Alabama Build-Out and Reports August 2025 Production Results
September 02, 2025
From
Digi Power X Inc.
Via
GlobeNewswire
Tickers
DGHI
DGXX
SMCI
TSX-V:DGHI
TSX-V:DGX
MediWound’s NexoBrid® to be Highlighted in 36 Scientific Presentations at the 21st European Burns Association Congress
September 02, 2025
From
MediWound Ltd.
Via
GlobeNewswire
Tickers
MDWD
< Previous
1
2
...
16
17
18
19
20
21
22
23
24
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.